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Abstract
Background: Hyperhomocysteinemia is regarded as a risk factor for cardiovascular diseases, diabetes and obesity.
Manifestation of these chronic metabolic disorders starts in early life marked by increase in body mass index (BMI). We
hypothesized that perturbations in homocysteine metabolism in early life could be a link between childhood obesity and
adult metabolic disorders. Thus here we investigated association of common variants from homocysteine metabolism
pathway genes with obesity in 3,168 urban Indian children.
Methodology/Principal Findings: We genotyped 90 common variants from 18 genes in 1,325 children comprising of 862
normal-weight (NW) and 463 over-weight/obese (OW/OB) children in stage 1. The top signal obtained was replicated in an
independent sample set of 1843 children (1,399 NW and 444 OW/OB) in stage 2. Stage 1 association analysis revealed
association between seven variants and childhood obesity at P,0.05, but association of only rs2796749 in AMD1 [OR = 1.41,
P= 1.5610-4] remained significant after multiple testing correction. Association of rs2796749 with childhood obesity was
validated in stage 2 [OR= 1.28, P= 4.2610-3] and meta-analysis [OR = 1.35, P= 1.9610-6]. AMD1 variant rs2796749 was also
associated with quantitative measures of adiposity and plasma leptin levels that was also replicated and corroborated in
combined analysis.
Conclusions/Significance: Our study provides first evidence for the association of AMD1 variant with obesity and plasma
leptin levels in children. Further studies to confirm this association, its functional significance and mechanism of action need
to be undertaken.
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Introduction
Childhood obesity is a growing public health issue world-
wide [1]. Prevalence of overweight/obesity has increased from
16% in 2002 to 24% in 2006 in urban school children in Delhi,
India [2]. Both genetic and environmental factors play an
important role in the development of obesity. Studies investigating
the genetic component of obesity have primarily focused on adult
obesity and around 32 obesity susceptibility genes have been
identified through large scale genome wide association studies
(GWAS) [3]. The search for genetic risk factors for childhood
obesity and related phenotypes are mainly limited to the
replication of variants identified through genome wide association
studies (GWAS) in adults [3].
Childhood obesity is one of the major determinants of many
chronic diseases in adulthood such as type 2 diabetes, hypertension
and cardio-vascular diseases [4]. Manifestation of these chronic
metabolic disorders, which have become pandemic in India [5–7],
starts in early life [8]. Indian subjects with impaired glucose
tolerance or diabetes are shown to have typically low BMI up to
the age of two years, followed by increasing BMI at the age of
12 years [8]. This suggests that molecular events leading to obesity
in childhood predispose individuals to chronic metabolic disorders
in later life. This makes identification of factors linking childhood
obesity and adult chronic disorders very imperative.
Elevated level of homocysteine, termed as hyperhomocysteine-
mia, is regarded as a potential risk factor for cardiovascular
diseases, diabetes, hypertension and number of other pathologies
[9–12]. Homocysteine is a thiol containing amino acid which plays
an important role in cell metabolism. The metabolic traffic of
homocysteine occurs either via remethylation to methionine or
through irreversible trans-sulfuration to cysteine. Homocysteine
metabolism involves a series of enzymatic reactions that produce
variety of metabolic intermediates which are important for cellular
processes such as transmethylation, transulfuration and polyamine
biosynthesis (Figure 1) [13]. Perturbations in the activities of
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enzymes involved in these processes such as methylene tetrahy-
drofolate reductase (MTHFR), methylene tetrahydrofolate dehy-
drogenase (MTHFD), methionine synthase reductase (MTRR),
cystathionine bsynthase (CBS) may results in altered levels of
homocysteine and thus metabolic disorders.
Contribution of variants in homocysteine pathway genes to
susceptibility of diabetes, obesity and vascular diseases has been
suggested by previous studies [14–16]. Genetic variants of
MTHFR, MTR and MTRR have been shown to be associated
with obesity [17]. The C677T polymorphism of MTHFR is
reported to be associated with hyperhomocysteinemia, type 2
diabetes and related complications [18,19]. However there is no
report of association of homocysteine pathway genes with
childhood obesity. Here we hypothesized that genetic variant in
homocysteine metabolism pathway genes leading to perturbation
in homocysteine metabolism might be a link between childhood
obesity and adult metabolic disorders. To test this, we designed the
present two stage case-control study to investigate association of 90
common variants from homocysteine metabolism pathway genes
with obesity in 3,168 urban Indian children.
Materials and Methods
Ethics Statement
The study was carried out in accordance with the principles of
Helsinki Declaration and was approved by Human Ethics
Committee of Institute of Genomics and Integrative Biology
(CSIR) and All India Institute of Medical Sciences Research Ethics
Committee. Informed written consent was obtained from all the
participants. Prior informed written consent was obtained from
parents/guardians of the children while verbal consent from
children themselves was taken.
Study Population
A total of 3,168 children (aged 11–17 years) were recruited from
school health survey from four different zones of Delhi (India) after
obtaining prior informed consent from school authorities, parents/
guardians and verbal consent from children themselves. For
stage 1, we selected 1,325 children [862 NW and 463 OW/OB] to
identify SNPs showing association with obesity. This was followed
by further selection of 1843 children (1,399 NW and 444 OW/
OB) in stage 2 for replication analysis. Subjects were classified as
normal-weight (NW) and over-weight/obese (OW/OB) based on
age and sex specific BMI cutoff provided by Cole et al [20], that
gives BMI cut offs for overweight and obesity by sex for children
between 2 and 18 years corresponding to the cut off points of 25
and 30 kg/m2 for adults.
Anthropometric and Clinical Measurements
Anthropometric measurements including height, weight, waist
circumference (WC) and hip circumference (HC) were taken using
standard methods. BMI and waist-to-hip ratio (WHR) were
calculated. Plasma levels of glucose, insulin and C-peptide were
measured as described earlier [21] and HOMA-IR was calculated
as described by Matthews et al. [22]. Plasma levels of leptin,
resistin and adiponectin were measured using commercial ELISA
kits (R&D Systems, Minneapolis, MN). Anthropometric and
clinical characteristics of subjects are provided in Table 1.
Genes and SNPs Selection
We selected 16 genes which have central role in the
homocysteine metabolism pathway (Figure 1) [13,23] and 2 genes
(ACE and NOS3) reported to be associated with plasma
homocysteine levels [24,25]. Common variants (MAF .0.05) of
the selected genes were prioritized based on previous reports of
association with metabolic disorders, tagging and linkage disequi-
librium (LD) pattern information, and spacing between the SNPs
to cover the gene. Finally a set of 90 SNPs were selected for
genotyping in stage 1 (Table S1).
Genotyping
Genotyping in stage 1 was performed using Illumina Gold-
enGate assay (Illumina Inc., San Diego, CA, USA). Stringent
quality control (QC) were applied to the genotyping data that
included genotype confidence score .0.25, SNP call rate .0.9,
GenTrans score .0.6, cluster separation score .0.4, Hardy
Weinberg Equilibrium (HWE) [P.0.01 in NW, OW/OB and all
subjects], minor allele frequency (MAF) .0.05. After excluding 35
SNPs based on QC criteria (Table S1), the successfully genotyped
Figure 1. Homocysteine metabolism pathway. The genes selected for the study are marked in red fonts. Refer to Table 2 for gene names. Figure
is adapted from Souto JC et al. (2005) Am J Hum Genet 76: 925–933 and Finkelstein JD (1998) Eur J Pediatr 157: S40–44.
doi:10.1371/journal.pone.0033162.g001
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SNPs had an average call rate of 98% and concordance rate
.99% based on 5% duplication.
In stage 2, variant showing strongest association with childhood
obesity and standing multiple testing correction was validated by
genotyping in an independent sample set of 1843 children (1,399
NW and 444 OW/OB) using iPLEX (Sequenom, San Deigo, CA,
USA). Genotyping success rate was 94% with.99.9% consistency
rate in genotype calls in 5% duplicates.
Statistical Analysis
Hardy Weinberg Equilibrium (HWE) was tested using x2.
Pairwise LD between the SNPs and haplotype blocks were
determined using Haploview 4.0. Continuous variables were
inverse normal transformed and were converted to age and sex
specific internal Z-scores by dividing differences of mean value of
study population and individual values by standard deviation.
Logistic and linear regression analyses were performed to assess
associations of variants with obesity and quantitative traits
respectively under additive model adjusting for age, sex and Z-
BMI as appropriate. A P value of ,7.7610-4 [0.05/(65] was
considered significant after Bonferroni correction. Meta-analysis
was performed by combining summary estimates while association
by combining raw genotyped data of two phases was also tested. b
values are presented as Z-score units. For continuous traits, P value
of ,5.5610-5 was considered statistically significant [0.05/
(65*14)]. Haplotype association analysis adjusted for age and sex
was carried out at 10,000 permutations. Statistical analyses were
performed using PLINK v. 1.07 (http://pngu.mgh.harvard.edu/
purcell/plink) and SPSS v. 17.0 (SPSS, Chicago, IL, USA).
Statistical power of the study was determined using Quanto
software (http://hydra.usc.edu/gxe/) assuming log additive model
of inheritance and 24% prevalence of overweight/obesity (1) at
a= 0.05. Sample size in stage 1 and combined analysis provided
44–76% and 76–97% power respectively to detect association of
variant with allele frequency of 0.20 and effect size of 1.20–1.30.
Results
Association analysis in stage 1 suggested association of seven
variants-rs2796749 (AMD1), rs7768897 (AMD1), rs1985908
(MAT1A), rs9397028 (MTHFD1L), rs1021737 (CTH), rs6693082
(CTH) and rs1801133 (MTHFR) with childhood obesity at P,0.05
(Tables 2 and 3). The association of rs2796749 in AMD1
[OR = 1.41, P= 1.5610-4] remained significant even after multi-
ple testing correction. Linear regression analysis to assess the
association of variants with BMI as continuous trait also revealed
association of rs2796749 with BMI [b= 0.16 Z-score unit,
P= 4.2610-4] (Table 3). AMD1 variant rs2796749 was also
associated with other quantitative measures of adiposity
(Table 4). With increase in per copy of risk allele G of
rs2796749, significant increase in height and weight by 0.10 Z-
score units (P= 0.02) and 0.17 (P= 1.3610-4) respectively was
observed (Table 4). Similar trend in increase in WC and HC was
found with the increase in risk allele of rs2796749 [b= 0.18,
P= 3.2610-5 for WC and b= 0.18, P= 4.4610-5 for HC]. The
Table 1. Clinical characteristics of subjects.
Character Stage 1 Stage 2 P{ P{
NW children OW/OB children NW children OW/OB children
N (M/F) 830 (370/464) 453 (173/279) 1399 (420/979) 444 (132/312)
Age (years) 14.00 (12.50–15.00) 13.00 (12.00–15.00) 13.00 (12.00–14.50) 13.2 (12.0–15.0) 3.0610-17 0.43
Height (m) 1.54 (1.48–1.61) 1.56 (1.50–1.62) 1.52 (1.46–1.58) 1.56 (1.51–1.62) 4.8610-8 0.24
Z-Height* -0.1160.99 0.2760.89 -0.1161.00 0.3560.93 0.93 0.18
Weight (kg) 42.30 (37.00–48.85) 64.00 (55.45–73.90) 42.00 (36.00–48.40) 63.5 (56.0–71.0) 0.18 0.73
Z-Weight* -0.5160.75 1.2060.54 -0.4060.70 1.1760.55 4.4610-4 0.35
BMI (kg/m2) 17.58 (15.86–19.44) 25.85 (23.97–28.97) 17.91 (16.26–19.78) 25.6 (24.0–28.0) 2.9610-3 0.14
Z-BMI* -0.5660.76 1.2760.49 -0.4060.65 1.1860.50 7.3610-7 0.01
WC (m) 0.66 (0.61–0.72) 0.84 (0.77–0.90) 0.65 (0.60–0.71) 0.85 (0.78–0.90) 4.2610-5 1.2610-3
Z-WC* -0.4260.77 1.1160.59 -0.4060.79 1.1160.63 1.49610-4 2.7610-13
HC (m) 0.81 (0.76–0.86) 0.97 (0.92–1.04) 0.80 (0.75–0.86) 0.97 (0.91–1.02) 8.3610-3 2.1610-8
Z-HC* -0.4260.76 1.2360.63 -0.4160.71 1.1160.62 0.11 1.4610-14
WHR 0.82 (0.78–0.87) 0.86 (0.81–0.90) 0.82 (0.78–0.86) 0.87 (0.83–0.92) 0.05 0.21
Z-WHR* -0.2260.89 0.4160.93 -0.2060.98 0.6260.96 0.14 1.3610-9
Glucose (mmol/L) 5.04 (4.72–5.33) 5.00 (4.72–5.33) 4.77 (4.44–5.11) 4.60 (4.22–4.90) 3.3610-23 6.3610-27
Insulin (pmol/L) 37.80 (23.40–54.60) 76.80 (52.20–108.00) 42.00 (28.80–58.80) 71.40 (47.40–111.60) 4.4610-5 1.8610-3
C-peptide (nmol/L) 0.46 (0.33–0.59) 0.61 (0.39–0.80) 0.48 (0.37–0.62) 0.70 (0.53–0.89) 0.86 0.19
HOMA-IR 1.41 (0.83–2.09) 2.83 (1.86–4.13) 1.44 (0.99–2.09) 2.41 (1.52–3.89) 8.1610-3 1.4610-4
hsCRP (mg/L) 0.25 (0.1–0.76) 1.26 (0.48–3.06) 0.34 (0.13–0.84) 1.11 (0.53–2.38) 3.0610-3 0.94
Adiponectin (mg/mL) 8.45 (5.95–12.50) 4.62 (2.81–7.18) 8.61 (4.80–13.59) 7.79 (4.76–10.83) 0.07 0.18
Leptin (ng/mL) 6.68 (4.30–11.51) 17.37 (10.72–26.81) 8.14 (5.10–12.75) 19.53 (13.43–30.34) 5.4610-5 3.0610-3
Resistin (ng/mL) 5.59 (4.39–7.82) 5.76 (4.33–7.25) 5.30 (4.25–6.80) 5.67 (4.60–7.25) 9.7610-3 7.6610-8
Data are presented as median with interquartile ranges.
*Data presented are mean values with standard deviation for Z-scores of the parameters.
doi:10.1371/journal.pone.0033162.t001
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Table 2. Homocysteine metabolism pathway genes and association analysis of their variants with obesity in Indian children.
Gene ID Gene name SNP ID Position in gene
Base
change AA change MAF NW
MAF OW/
OB OR (95%CI) P
MTHFR Methylenetetrahydrofolate
reductase
rs3737965 Intron 1 G/A 0.09 0.08 0.86 (0.63–1.18) 0.36
rs9651118 Intron 2 T/C 0.28 0.25 0.84 (0.69–1.01) 0.07
rs1801133 Exon 4 C/T A222V 0.17 0.20 1.24 (1.01–1.52) 0.04
rs1801131 Exon 7 A/C E429A 0.38 0.41 1.12 (0.95–1.32) 0.19
CTH Cystathionase rs663465 5’ flank C/T 0.43 0.45 1.1 (0.93–1.30) 0.27
rs663649 Intron 7 C/A 0.18 0.19 1.04 (0.84–1.29) 0.70
rs1021737 Exon 12 G/T S403I 0.25 0.29 1.26 (1.05–1.52) 0.01
rs6693082 3’ flank T/G 0.25 0.30 1.26 (1.05–1.51) 0.01
MTR 5-methyltetrahydrofolate-
homocysteine
rs946403 Intron 13 A/G 0.37 0.41 1.16 (0.98–1.38) 0.09
methyltransferase rs1770449 Intron 24 A/G 0.30 0.28 0.91 (0.76–1.08) 0.27
rs1805087 Exon 26 T/C D919G 0.31 0.30 0.95 (0.79–1.13) 0.55
rs16834521 Exon 28 A/G A1048A 0.31 0.34 1.15 (0.97–1.37) 0.12
rs2229276 Exon 29 A/G A1048A 0.31 0.34 1.16 (0.97–1.38) 0.10
rs1050993 3’ UTR C/T 0.29 0.28 0.91 (0.76–1.09) 0.31
CHDH Choline dehydrogenase rs6445607 Intron 1 T/G 0.25 0.27 1.14 (0.94–1.39) 0.17
rs2241808 Exon 4 A/G A240A 0.41 0.43 1.09 (0.92–1.28) 0.34
MTRR Methionine synthase reductase rs1801394 Exon 2 G/A I22M 0.45 0.50 1.18 (1.00–1.40) 0.05
rs162036 Exon 7 T/C K350R 0.14 0.16 1.14 (0.90–1.43) 0.27
rs10380 Exon 14 G/A H595Y 0.14 0.15 1.10 (0.87–1.39) 0.42
BHMT Betaine-homocysteine S-
methyltransferase
rs492842 Intron 1 T/C 0.43 0.40 0.87 (0.74–1.03) 0.10
rs3733890 Exon 6 C/T R239Q 0.28 0.27 0.95 (0.78–1.14) 0.56
rs585800 3’ UTR A/T 0.14 0.13 0.87 (0.68–1.12) 0.27
AMD1 Adenosylmethionine
decarboxylase 1
rs2796749 5’ flank C/G 0.34 0.27 0.71 (0.59–0.85) 1.5610-
4
rs1007274 Intron 1 G/A 0.24 0.27 1.10 (0.91–1.33) 0.31
rs7768897 Intron 4 C/T 0.25 0.20 0.77 (0.63–0.93) 7.5610-
3
NOS3 Nitric oxide synthase 3 rs1799983 Exon 7 G/T D298E 0.17 0.19 1.14 (0.92–1.41) 0.22
rs2566514 Exon 18 G/C A666A 0.35 0.34 0.94 (0.80–1.12) 0.50
MAT1A Methionine adenosyltransferase I rs17677908 5’ flank T/C 0.26 0.29 1.16 (0.96–1.39) 0.12
rs2282367 Intron 4 G/A 0.15 0.14 0.94 (0.75–1.19) 0.63
rs10788546 Exon 7 C/T V290V 0.16 0.15 0.97 (0.77–1.22) 0.79
rs2993763 Exon 9 A/G Y377Y 0.38 0.35 0.88 (0.74–1.04) 0.14
rs1985908 3’ UTR T/C 0.48 0.42 0.78 (0.66–0.92) 4.0610-
3
FOLH1 Folate hydrolase 1 rs202719 Intron 11 T/C 0.11 0.13 1.24 (0.97–1.59) 0.086
rs6485965 3’ flank G/A 0.38 0.37 0.96 (0.80–1.15) 0.67
MTHFD1 Methylenetetrahydrofolate
dehydrogenase 1
rs8006686 Intron 2 T/C 0.17 0.17 0.99 (0.79–1.23) 0.90
rs1950902 Exon 6 G/A) K134R 0.08 0.07 1.00 (0.72–1.38) 0.99
rs8016556 Intron 16 A/G 0.26 0.24 0.90 (0.74–1.09) 0.27
rs2236225 Exon 20 T/C R653Q 0.50 0.49 0.93 (0.78–1.11) 0.41
rs2281603 Intron 26 T/C 0.21 0.20 0.95 (0.78–1.17) 0.64
MTHFD1L Methylenetetrahydrofolate
dehydrogenase 1-like
rs9397028 5’ flank G/A 0.42 0.37 0.80 (0.67–0.95) 0.01
rs2073063 Intron 4 A/G 0.43 0.39 0.84 (0.71–1.00) 0.05
rs1555179 Intron 15 C/T 0.24 0.23 0.95 (0.79–1.15) 0.61
rs509474 Exon 23 G/C S832S 0.33 0.32 0.98 (0.81–1.17) 0.78
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rs2796749 was also associated with plasma leptin level [b= 0.14,
P= 4.2610-4].
Because of strong association of AMD1 variant rs2796749 with
childhood obesity and measures of adiposity, we attempted to
replicate the signal obtained at rs2796749 in additional sample set
of 1843 children in stage 2. Association of rs2796749 with
childhood obesity was validated in stage 2 [OR = 1.28,
P= 4.2610–3] and was confirmed by meta-analysis [OR = 1.35,
P= 2.7610–6] (Table 3). Similar results were obtained in
combined analysis by pooling genotype data from two stages
[OR = 1.35, P= 1.9610–6]. Consistently, association of rs2796749
with BMI was also replicated [b= 0.10, P= 2.6610–3]. The meta-
analysis and combined analysis corroborated the association of
rs2796749 [b= 0.12, P= 6.5610-6 in meta-analysis and b= 0.13,
P= 2.56 10–6 in combined analysis]. Association of rs2796749
with measures of adiposity and plasma leptin levels was also
replicated in stage 2 and was corroborated in combined analysis
(Figure 2). No association of rs2796749 with other biochemical
traits investigated could be detected (Table 4).
Stage 1 analysis also suggested association of MAT1A variant
rs1985908 with childhood obesity [OR = 1.28, P= 4.0610–3],
BMI [b= 0.14, P= 1.5610–3] and leptin levels [b= –0.12,
P= 2.7610–3]. CTH variant rs6693082 which showed nominal
association with obesity, was also found to be associated with BMI
[P= 9.1610–4], WC [P= 4.0610–4], HC [P= 6.3610-4] and
adiponectin levels [P= 4.5610–3] (Table S2). However the
associations of rs1985908 and rs6693082 with obesity and other
traits did not remain significant after correcting for multiple
comparisons.
Further, we investigated the association of all the SNPs
genotyped in stage 1 with quantitative traits related to obesity
that included measures of glucose homeostasis, lipid metabolism
and adipokines. We observed suggestive association of some
variants with quantitative traits (Table S2). CTH variant
rs1021737 showed association with total cholesterol (P= 6.8610-3]
while MAT1A variant rs17677908 and MTR variant rs16834521
were found to be associated with TG [P= 6.8610-3 and 3.56610-3
respectively]. Besides AMD1 and MAT1A, levels of leptin were also
associated with MTRR variant rs1801394 [P= 6.8610-3]. How-
ever, none of the associations remained significant after accounting
for multiple tests. We also performed haplotype association
analysis that suggested association of haplotypes of variants SNPs
in AMD1, CTH, MTHFR and MTRR (Table S3). None of the
haplotype associations remained significant after 10,000 permu-
tations.
Discussion
Several GWAS and large-scale meta-analysis for adult BMI
have identified susceptibility loci for increased BMI, explaining
only a small proportion of variation in BMI [3]. Investigation of
genetic risk factors for childhood obesity has been restricted
mainly to the replication of GWAS findings [3]. Though modern
genotyping arrays capture most of the common variations, there
Table 2. Cont.
Gene ID Gene name SNP ID Position in gene
Base
change AA change MAF NW
MAF OW/
OB OR (95%CI) P
rs1047662 3’ UTR C/G 0.28 0.27 0.97 (0.80–1.16) 0.71
SHMT1 Serine hydroxymethyltransferase 1rs2273028 Intron 7 C/T 0.16 0.17 1.01 (0.81–1.25) 0.94
rs1979277 Exon 12 G/A L474F 0.16 0.15 0.99 (0.80–1.24) 0.96
rs12949119 3’ UTR A/T 0.36 0.35 0.97 (0.81–1.16) 0.71
ACE Angiotensin I converting enzyme rs4291 5’ flank A/T 0.39 0.39 1.03 (0.87–1.23) 0.71
rs4331 Exon 16 C/T A731A 0.41 0.43 1.13 (0.96–1.33) 0.16
rs4362 Exon 24 C/T F1129F 0.35 0.38 1.16 (0.97–1.39) 0.10
AHCY Adenosylhomocysteinase rs819146 5’ UTR A/C 0.22 0.21 0.94 (0.77–1.15) 0.56
rs819147 Intron 2 T/C 0.23 0.21 0.89 (0.73–1.09) 0.25
rs864702 Intron 10 C/T 0.23 0.21 0.88 (0.72–1.08) 0.22
rs819173 3’ flank T/C 0.24 0.21 0.88 (0.72–1.08) 0.21
CBS Cystathionine-beta-synthase rs706208 3’ UTR T/C 0.38 0.37 0.94 (0.80–1.12) 0.51
rs6586282 Intron 15 G/A 0.08 0.07 0.89 (0.65–1.20) 0.43
rs2014564 Intron 12 G/A 0.47 0.46 0.98 (0.83–1.16) 0.83
rs234706 Exon 9 C/T Y233Y 0.23 0.24 1.05 (0.87–1.28) 0.60
SLC19A1 Solute carrier family 19 member 1 rs1051296 3’ UTR A/C 0.47 0.45 0.91 (0.77–1.07) 0.24
rs12659 Exon 3 G/A P114P 0.34 0.34 1.03 (0.87–1.22) 0.76
rs1051266 Exon 2 G/A H27R 0.38 0.38 0.99 (0.84–1.17) 0.89
TCN2 Transcobalamin II rs5749131 5’ flank A/G 0.37 0.37 0.98 (0.83–1.16) 0.81
rs9606756 Exon 2 T/C I23V 0.09 0.11 1.11 (0.84–1.46) 0.47
rs1801198 Exon 6 G/C R259P 0.41 0.43 1.08 (0.92–1.28) 0.35
rs9621049 Exon 7 G/A S348F 0.08 0.09 1.18 (0.88–1.58) 0.26
rs10418 3’ UTR G/A 0.21 0.19 0.88 (0.72–1.09) 0.24
AA: Amino acid; MAF: minor allele frequency; OR: odds ratio; CI: confidence interval. OR and P values presented were calculated using logistic regression analysis under
additive model with age and sex as covariates.
doi:10.1371/journal.pone.0033162.t002
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Table 3. Association of homocysteine metabolism pathway genes with obesity in urban Indian children.
SNP Gene
RAF NW
children
RAF OW/OB
children Obesity BMI
OR (95%CI) P b SE P
Stage 1
rs2796749 (C/G) AMD1 0.657 0.733 1.41 (1.18–1.69) 1.5610-4 0.16 0.05 4.2610-4
rs7768897 (C/T) AMD1 0.745 0.795 1.30 (1.07–1.59) 7.5610-3 0.11 0.05 0.03
rs1985908 (T/C) MAT1A 0.524 0.581 1.28 (1.09–1.51) 4.0610-3 0.14 0.04 1.5610-3
rs9397028 (G/A) MTHFD1L 0.577 0.627 1.25 (1.05–1.49) 0.01 0.15 0.05 1.3610-3
rs1021737 (G/T) CTH 0.250 0.292 1.26 (1.05–1.52) 0.01 0.16 0.05 1.6610-3
rs6693082 (T/G) CTH 0.250 0.300 1.26 (1.05–1.51) 0.01 0.16 0.05 9.1610-4
rs1801133 (C/T) MTHFR 0.169 0.203 1.23 (1.01–1.52) 0.04 0.12 0.06 0.02
Stage 2
rs2796749 (C/G) AMD1 0.668 0.723 1.28 (1.09–1.54) 4.2610-3 0.10 0.03 2.6610-3
Combined
rs2796749 (C/G) AMD1 0.664 0.728 1.35 (1.19–1.52) 1.9610-6 0.13 0.03 2.5610-6
Meta-analysis*
rs2796749 (C/G) AMD1 1.35 2.7610-6 0.12 6.5610-6
RAF: risk allele frequency; OR: odds ratio. Odds ratio are presented with respect to risk allele that are highlighted as underlined text. b: change in Z score of BMI per
increase in risk allele; SE: standard error. Combined analysis was performed by combining raw genotype data from stage 1 and stage 2. Meta-analysis was performed by
combining the summary estimates (OR/b, 95%CI and S.E). No heterogeneity in two study population was observed (P value for Cochrane’s Q statistic = 0.48 and Iˆ2
heterogeneity index = 0.0). *OR/b and P value for fixed effect meta-analysis.
doi:10.1371/journal.pone.0033162.t003
Table 4. Association of AMD1 variant rs2796749 with clinical traits in urban Indian children.
Stage 1 Stage 2 Combined Mean
Trait b P b P b P CC CG GG
Height{ 0.10 0.02 0.09 0.01 0.09 6.7610–4 20.20 0.01 0.04
Weight{ 0.17 1.3610–4 0.12 2.8610–4 0.14 9.1610–8 20.17 20.05 0.10
BMI{ 0.16 4.2610–4 0.10 2.6610–3 0.13 2.5610–6 20.11 20.06 0.10
WC{ 0.18 3.2610–5 0.11 2.5610–3 0.14 3.2610–7 20.16 20.06 0.10
HC{ 0.18 4.4610–5 0.12 3.3610–4 0.16 3.7610–8 20.17 20.05 0.12
WHR{ 0.07 0.07 0.04 0.27 0.06 0.05 20.07 20.04 0.03
Adiponectin{ 20.03 0.49 20.01 0.71 20.02 0.41 20.08 0.04 0.00
Leptin{ 0.14 4.2610–4 0.09 0.02 0.12 2.2610–5 20.01 20.01 0.06
Resistin{ 0.01 0.82 0.02 0.60 0.01 0.74 20.01 0.01 0.01
hsCRP{ 0.08 0.08 0.06 0.11 0.07 0.01 0.03 20.03 0.02
Total
Cholesterol{
20.009 0.84 0.07 0.03 0.04 0.12 0.01 20.05 20.003
HDL{ 20.07 0.05 0.009 0.81 20.03 0.35 20.003 20.001 20.01
LDL{ 0.02 0.65 0.08 0.02 0.06 0.04 20.01 20.02 0.03
TG{ 0.06 0.10 20.03 0.45 0.01 0.73 0.07 0.05 0.05
FPG{ 20.03 0.47 0.002 0.94 0.07 0.01 20.02 0.05 0.001
FPI{ 0.06 0.15 0.07 0.06 20.01 0.67 20.08 0.03 20.005
C-peptide{ 0.08 0.05 0.03 0.36 0.06 0.04 20.09 0.06 20.01
HOMA-IR{ 0.05 0.27 0.07 0.05 0.07 0.02 20.09 0.04 20.01
b represents change in Z score per increase in risk allele. The mean values presented were obtained by ANCOVA analysis adjusted for appropriate covariates.
{Analysis performed after adjusting for age and sex.
{Analysis performed after adjusting for age, sex and BMI.
doi:10.1371/journal.pone.0033162.t004
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remain substantial additional contributions to phenotypic varia-
tion from the variants not well captured by these arrays [26].
Investigation of variants prioritized based on their functional and
positional significance provides an opportunity to identify those
not detected by GWAS. Employing functional candidate analysis,
we recently identified association of common variants of IL6,
LEPR, and PBEF1 with increased susceptibility to obesity and
measures of adiposity in Indian children [27]. Homocysteine
metabolism pathway seems to be a promising candidate pathway
by virtue of its involvement in important cellular processes. Thus,
here we comprehensively examined association of common
variants of homocysteine metabolism pathway genes with obesity
in children.
The study reveals association of AMD1 variant rs2796749 with
obesity, measures of adiposity and plasma leptin levels in urban
Indian children. To the best of our knowledge, this is the first study
demonstrating the association of AMD1 variant with obesity. In
our previous study of association of homocysteine metabolism
pathway genes with type 2 diabetes and adult obesity [28],
rs2796749 did not show association with adult obesity or BMI but
was directionally consistent. Further, we investigated effect of this
variant on adult BMI using the association data from GIANT
consortium GWA meta-analysis which included 249,796 individ-
uals of European ancestry [29]. In this recent meta-analysis also,
rs2796749 showed consistency in direction of association with
BMI, though could not reach statistical significance (P= 0.19).
This suggests that AMD1 variant rs2796749 might have influence
on adult BMI also, but with smaller effect size.
AMD1 codes for an important regulatory enzyme adenosyl-
methionine decarboxylase 1 (AdoMetDC) which catalyzes the
decarboxylation of S-adenosyl methionine (SAM), a methyl-group
donor in transmethylation reactions. The imbalances in decar-
boxylation of SAM might result in disruption of DNA methylation
process leading to abnormal gene expressions [30], which is
implicated in various metabolic disorders including obesity and
diabetes [31]. In addition to its role in transmethylation reaction,
AdoMetDC is also a regulatory enzyme in polyamine biosynthesis.
SAM is committed to polyamine bio-synthesis after decarboxyl-
ation and serves as an aminopropyl donar in spermidine and
spermine synthesis [32]. The polyamines are ubiquitous and are
Figure 2. Association of rs2796749 with clinical traits in urban Indian children. Mean Z-scores adjusted for age and sex are plotted on the
y-axis for the corresponding genotypes on x-axis for all the traits except leptin for which the mean Z-scores are adjusted for age, sex and Z-BMI.P
values presented were determined by linear regression analysis for Z-score change per risk allele of the respective trait.
doi:10.1371/journal.pone.0033162.g002
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implicated in cellular growth and differentiation, regulation of
adipocyte formation and glucose metabolism [33].
A recent study reported increased levels of polyamines in
childhood obesity and their correlation with biomarkers of
oxidative stress, inflammation and leptin [34]. The study
supported the role of polyamines on growth and development
on adipose tissue. On similar lines, our study demonstrated
association of rs2796749 in 5? flank region of AMD1 with obesity
in Indian children. The same variant also showed association with
quantitative measures of adiposity including weight, BMI, hip and
waist circumferences and plasma levels of leptin. Moreover, AMD1
mRNA is shown to increase in response to insulin via insulin
response element in 5’ flank region of AMD1 [35]. The variant
rs2796749 might also have role in influencing the transcription of
AMD1 in response to insulin, which needs to be investigated.
MAT1A codes for methionine adenosyltransferase (MAT),
which catalyzes the conversion of methionine to S- adenosylme-
thionine (SAM). MAT1A variants have been shown to be
associated with hypertension and stroke [36]. Our study also
suggested association of MAT1A variant rs1985908 with childhood
obesity. MAT1A variants also showed association with the plasma
levels of leptin, adiponectin and triglyerides. But these associations
could not stand multiple testing corrections, hence further
replication in larger sample set and in other ethnic groups are
required to substantiate the observations in the present study.
Although the present study design limits the potential to identify
the causal relationships, based on previous studies, we can
speculate that AMD1 variant might influence the susceptibility to
obesity by modulating either the polyamines metabolism or DNA
methylation. Dietary habits can affect these processes as nutrients
such as vitamin B12 and folate are required as important cofactors
in these enzymatic reactions (Figure 1). The plasma levels of folate
and vitamin B12 as well as the dietary intake of these are inversely
correlated with the plasma homocysteine levels [37]. Moreover,
individuals consuming only vegetarian diet tend to have low
vitamin B12 and elevated homocysteine levels [38,39]. Majority of
Indian population adheres to a vegetarian diet that predisposes
them to vitamin B12 deficiency. Thus diet which can influence the
availability of vitamins may modulate the impact of genetic
variants on obesity phenotypes. Previous studies including
investigation in Indian populations suggested the possibility of
interaction between diet and genetic variants of homocysteine
pathway genes in influencing the homocysteine levels [40],
however no study provided strong evidence for this interaction
and its impact on impact on phenotypes. Unfortunately, lack of
data on the levels of folate and vitamin B12 and the dietary habits
of our study subjects limited further investigation of the interaction
of these factors with the genetic variants and their combined effect
on obesity phenotypes.
In case-control association studies, limited statistical power and
population stratification can lead to spurious association results.
Though the sample size of our study is considerable, there is a
likelihood of false negative observations for variants with small
effect sizes, as the present study is sufficiently powered to capture
only large effects (OR.1.3) of the common variants with
frequencies more than 0.20. Further, to minimize the effect of
population stratification, we have collected samples from a small
geographical region that forms a homogenous cluster as reported
by the Indian Genome Variation Consortium [41]. Moreover, the
multidimensional scaling (MDS) analysis using the genotype data
for 595 unlinked markers (r2,0.20) for stage 1 samples shows that
the study population belongs to one cluster (Figure S1).
In conclusion, we demonstrate here, for the first time,
association of AMD1 variant with susceptibility to obesity and
measures of adiposity in Indian children. Further studies to
confirm the association of AMD1 variant with childhood, its
functional significance and molecular mechanism need to be
undertaken. Moreover, our study provides a lead for future
investigations towards understanding the genetic predisposition of
obesity in childhood and exploring therapeutic options for
prevention of childhood obesity.
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